We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

86 hedge funds and large institutions have $301M invested in Lifecore Biomedical in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 29

1.5% more ownership

Funds ownership: 90.54% → 92.04% (+1.5%)

8% less funds holding

Funds holding: 93 → 86 (-7)

12% less capital invested

Capital invested by funds: $340M → $301M (-$39.2M)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
86
Holders Change
-7
Holders Change %
-7.53%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
32
Reduced
29
Closed
8
Calls
$12K
Puts
–
Net Calls
+$12K
Net Calls Change
-$209K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$23.3M
2
NIMC
NWQ Investment Management Company
California
+$8.7M
3
Boston Partners
Boston Partners
Massachusetts
+$973K
4
RA
Royce & Associates
New York
+$772K
5
FP
Foundry Partners
Minnesota
+$708K

Top Sellers

Rank Fund Capital Flow
1
GC
Guggenheim Capital
Illinois
-$2.19M
2
AI
Ariel Investments
Illinois
-$1.56M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.23M
4
PPA
Parametric Portfolio Associates
Washington
-$778K
5
CIP
Chartwell Investment Partners
Pennsylvania
-$566K
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$1.87M +$70.1K +5,538 +4%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$1.81M +$13 +1 +0%
Bank of America
28
Bank of America
North Carolina
$1.47M +$138K +10,865 +10%
PPA
29
Parametric Portfolio Associates
Washington
$1.42M -$778K -61,466 -34%
Charles Schwab
30
Charles Schwab
California
$1.27M +$67.1K +5,301 +5%
AA
31
Ancora Advisors
Ohio
$926K – – –
TCIM
32
TIAA CREF Investment Management
New York
$894K -$72K -5,690 -7%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$809K -$36.7K -2,900 -4%
Neuberger Berman Group
34
Neuberger Berman Group
New York
$701K -$19K -1,500 -3%
PA
35
Pinnacle Associates
New York
$663K +$211K +16,650 +43%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$645K -$16.5K -1,300 -2%
Goldman Sachs
37
Goldman Sachs
New York
$577K +$29.3K +2,311 +5%
TA
38
Teachers Advisors
New York
$574K +$27.4K +2,165 +5%
Invesco
39
Invesco
Georgia
$552K +$70.9K +5,601 +14%
State Board of Administration of Florida Retirement System
40
State Board of Administration of Florida Retirement System
Florida
$531K – – –
WCM
41
Wedge Capital Management
North Carolina
$521K – – –
CAM
42
Congress Asset Management
Massachusetts
$521K +$211K +16,655 +62%
Swiss National Bank
43
Swiss National Bank
Switzerland
$484K – – –
BCM
44
Buckhead Capital Management
Georgia
$481K +$147K +11,605 +41%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$463K +$71.7K +5,660 +17%
CS
46
Credit Suisse
Switzerland
$449K +$47.4K +3,747 +11%
Morgan Stanley
47
Morgan Stanley
New York
$446K -$536K -42,354 -53%
CCB
48
Cutter & Co Brokerage
Missouri
$389K +$45.6K +3,600 +13%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$272K +$40K +3,156 +16%
UBS Group
50
UBS Group
Switzerland
$242K -$16.9K -1,338 -6%
1
2
3 4

LFCR Hedge Fund Activity: Q1 2017 in Review

86 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q1 2017, worth a combined $301M — down 12% from $340M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of LFCR and 6 opened new positions — a net loss of 2 holders — while 29 trimmed existing stakes and 32 added.

The largest buyer was BlackRock, adding an estimated $23.3M. The largest seller was Guggenheim Capital, exiting entirely with an estimated $2.19M sold.

  • 86 institutional investors held Lifecore Biomedical (LFCR) as of Q1 2017, down from 93 in Q4 2016.
  • Funds reported $301M of Lifecore Biomedical stock for Q1 2017, down 12% quarter-over-quarter.
  • 6 funds opened new Lifecore Biomedical positions in Q1 2017 and 8 closed out, a net change of -2 holders.
  • The largest Lifecore Biomedical buyer in Q1 2017 was BlackRock, an estimated $23.3M added.
  • The largest Lifecore Biomedical seller in Q1 2017 was Guggenheim Capital, an estimated $2.19M sold.

Based on aggregated 13F filings for Q1 2017.